Soligenix Director Receives 17,647 Stock Options at $1.70 Strike Price
Form 4 filing reveals that Diane L. Parks, Director at Soligenix, received a stock option grant on June 20, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Form 4 filing reveals that Diane L. Parks, Director at Soligenix, received a stock option grant on June 20, 2025. The derivative securities transaction details include:
- Granted 17,647 stock options to purchase common stock
- Exercise price set at $1.70 per share
- Options expire on June 20, 2035
- Vesting schedule occurs in four equal installments: - September 20, 2025 - December 20, 2025 - March 20, 2026 - June 20, 2026
This stock option grant represents standard director compensation and aligns the director's interests with shareholders through long-term equity incentives. The 10-year exercise period provides significant time value for these options.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 17,647 | $0.00 | $0.00 |
Footnotes (1)
- F1. The stock option vests ratably on each of September 20, 2025, December 20, 2025, March 20, 2026 and June 20, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock options were granted to Diane Parks at SNGX on June 20, 2025?
What is the vesting schedule for SNGX director Diane Parks' stock options granted in June 2025?
What position does Diane Parks hold at Soligenix (SNGX)?
What is the total value of stock options granted to SNGX's Diane Parks in June 2025?
AI-generated analysis. How Rhea-AI works. Not financial advice.